Developer docs
API playgroundTry for free, no card

Search company profiles

Specific Pharma

Full company profile

uuid002bw78

Namestring
Specific Pharma
Legal namestring
Specific Pharma A/S
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Specific Pharma A/S is a Copenhagen-headquartered pharmaceutical services company, founded in 2010 as a spin-off from Danish wholesaler Nomeco to serve unmet demand for unlicensed medicines not marketed in Denmark. The company has since become the largest provider of unlicensed medicines and clinical trial supply in the Nordic countries and operates as a wholly-owned subsidiary of PHOENIX group, the European pharmaceutical wholesaler spanning 26 countries. Its service portfolio combines two interrelated lines: (1) sourcing and distribution of unlicensed and named-patient medicines to patients, healthcare professionals, pharmacies, and hospitals, and (2) Clinical Trial Supply Management (CTSM), which integrates study planning, GMP-compliant packaging and labelling (including Just-In-Time and double-blinded setups), global IMP distribution with temperature-controlled logistics, IMP expiry extension, clinical pass-through, and returns handling. The company also offers MA-Holder services covering post-trial access, shortage mitigation, staggered launches, and discontinuation management, alongside multi-temperature warehousing and distribution across facilities in Denmark, Sweden, and the Netherlands.

The underlying operating backbone is a regulatory-grade pharmaceutical logistics platform with GDP- and GMP-compliant infrastructure, a Quality Management System, and a full set of Danish-issued authorisations (GDP human and veterinary, GMP IMP/human/veterinary, MIA, WDA, EUF for controlled substances). Proprietary operational capabilities include CTSM as a specialised sub-brand, documented IMP expiry extension, and pharmacist-led sourcing across a network of 75 suppliers worldwide. The technology layer is process- and compliance-driven rather than software-driven; no APIs, SDKs, or AI/ML components are disclosed, and the platform is differentiated by regulatory licensing, physical infrastructure, and domain expertise rather than algorithmic tooling.

Specific Pharma monetises through a mix of transaction-fee-based unlicensed medicine distribution, professional services for CTSM engagements, managed services for warehousing and distribution, and fee-based MA-Holder services. The go-to-market is sales-led, executed by territory-specific Business Development Managers and Key Account Managers covering Denmark, Sweden, Holland/Norway, and the Baltics/Iceland/export markets, with direct engagement supported by a LinkedIn presence and a self-service client web portal. Pricing is not publicly disclosed and is contracted per engagement. Roughly half of revenue is generated outside Denmark via export, and the company reports support for 100+ clinical studies across 20+ countries.

Short descriptiontext

Specific Pharma A/S is a Copenhagen-based pharmaceutical services company and subsidiary of PHOENIX group that supplies unlicensed medicines and provides Clinical Trial Supply Management to patients, healthcare professionals, and pharmaceutical companies across Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCopenhagen, Denmark
HQ citystring
Copenhagen
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial supply, unlicensed medicines, pharmaceutical distribution, investigational medicinal products, pharmaceutical logistics services
Industry2 codes
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Distribution & Clinical Trial Supply Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Unlicensed Medicines Distribution
TypeTransaction Fee
Description

Sourcing and distributing unlicensed medicines to patients with unmet medical needs, healthcare professionals, and pharmacies. Services provided on named patient basis, compassionate use permit, or special permit basis.

specificpharma.com
2Clinical Trial Supply Management (CTSM)
TypeProfessional Services
Description

Comprehensive services for clinical trial supply including product forecasting, study planning, IMP packaging and labeling, global distribution, and returns handling. Supports both global pharmaceutical companies and investigator-initiated trials.

specificpharma.com
3MA-Holder Services
TypeTransaction Fee
Description

Assisting pharmaceutical companies in making products available across European countries prior to and after marketing authorisation. Includes post-trial access, temporary supply during drug shortages, staggered global launches, and discontinuation management.

specificpharma.com
4Warehousing and Distribution
TypeManaged Services
Description

Storage and distribution services for pharmaceutical companies in Denmark, Sweden, and the Netherlands. Covers ambient, cold chain, frozen temperatures, controlled drugs, and cytostatic agents. GDP-compliant facilities.

specificpharma.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1CTSM (Clinical Trial Supply Management)
Description

A highly specialised department providing solutions within clinical trial supply, offering warehousing, distribution, packaging, forecasting, and more for clinical trials.

specificpharma.com
Core offering1 text field

Specific Pharma sources, warehouses, and distributes unlicensed medicines for patients with unmet medical needs and provides Clinical Trial Supply Management (CTSM) for global clinical trials, including study planning, GMP packaging and labelling, IMP distribution, returns, and IMP expiry extension. Operations are run from GDP- and GMP-compliant facilities in Denmark, Sweden, and the Netherlands, serving pharmaceutical companies, healthcare professionals, and patients in Europe and internationally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 1,000 products available quickly
+2 more records
Product overview1 text field

Specific Pharma operates as a unified pharmaceutical services platform offering two core service areas: unlicensed medicines provision (including named patient basis, compassionate use, and special permits) and Clinical Trial Supply Management (CTSM). The CTSM department integrates multiple service modules including Study Planning, Packaging and Labeling, Distribution and Returns, and Warehousing across facilities in Denmark, Sweden, and the Netherlands. The MA-Holder Services module extends support throughout the pharmaceutical product lifecycle. Together, these services provide end-to-end pharmaceutical logistics and access solutions for patients, healthcare professionals, and pharmaceutical companies across Europe and globally.

Product and service7 records
1Unlicensed Medicines
CategoryUnlicensed medicines supply
Description

Core offering: sourcing and distributing medicines not marketed in the customer's country on named patient basis, compassionate use permit, or special permit. Served to patients with unmet medical needs, healthcare professionals, and pharmacies in the Nordics and beyond.

2Clinical Trial Supply Management (CTSM)
CategoryClinical trial supply services
Description

Comprehensive clinical trial supply service covering warehousing, distribution, packaging, forecasting, and return handling. Supports global pharmaceutical companies and investigator-initiated trials across more than 20 countries.

3MA-Holder Services
CategoryMarket access / MA-holder services
Description

Support for pharmaceutical companies throughout the product lifecycle: post-trial patient access, temporary supply during drug shortages, staggered global launches, and discontinuation management across European countries before and after marketing authorisation.

4Warehousing and Distribution
CategoryPharmaceutical logistics services
Description

GDP-compliant storage and global distribution of pharmaceutical products, covering ambient, cold chain, frozen temperatures, controlled drugs, and cytostatic agents from facilities in Denmark, Sweden, and the Netherlands.

5Study Planning
CategoryClinical trial supply services
Description

Clinical trial supply expertise including product forecast, shipment setup design, ongoing site resupply, packaging design, and comparator sourcing for global studies.

6Packaging and Labeling
CategoryClinical trial manufacturing services
Description

GMP repackaging and labelling services for marketed and IMP products, including customised clinical trial packaging, Just-in-Time labelling, double-blinded setup, and secondary packaging to support protocol changes.

7Distribution and Returns
CategoryClinical trial distribution services
Description

Global IMP distribution with full traceability, IMP expiry extension, Clinical Pass-Through import control with direct delivery to site personnel in Denmark, import/export of controlled substances with annual reporting, and documented return and destruction handling.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Specific Pharma is a subsidiary of PHOENIX group, Europe's leading pharmaceutical wholesaler operating across 26 European countries. PHOENIX group provides corporate governance, data protection policies, compliance frameworks, and reporting systems. The relationship is parent-subsidiary rather than a traditional partnership.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Large, US-listed pharma services platform covering clinical supply services, softgel and biologics manufacturing, and drug development. Overlaps with Specific Pharma on CTSM within a much broader service portfolio.

TypeDirect peer
Description

UPS Healthcare-owned global clinical trial supply chain and logistics provider offering IMP distribution, cold chain, and returns management. Closely mirrors Specific Pharma's CTSM distribution and returns service.

TypeDirect peer
Description

UK-headquartered specialty pharma company focused on the supply of unlicensed, compassionate-use, and expanded-access medicines plus clinical trial supply services. Directly comparable to Specific Pharma in named-patient distribution and CTSM offerings.

TypeDirect peer
Description

Northern Ireland-headquartered pharma services firm providing clinical trial packaging, labeling, distribution, and returns services. Direct overlap with Specific Pharma's Packaging & Labeling and CTSM modules.

5Fisher Clinical Services (Thermo Fisher Scientific / PPD)
TypeDirect peer
Description

Integrated within Thermo Fisher's PPD clinical research services, providing global clinical trial supply, packaging, and distribution. Competes for the same multinational pharma CTSM accounts as Specific Pharma.

TypeBroad incumbent
Description

Largest global CRO and life sciences services firm with integrated clinical trial supplies capabilities. Competes for enterprise CTSM contracts that Specific Pharma also targets, though as part of a far broader clinical research stack.

TypeDirect peer
Description

UK-based specialist pharmaceutical wholesaler distributing unlicensed medicines, clinical trial supplies, and named-patient products globally. Directly comparable niche peer for unlicensed medicines and CTSM distribution.

TypeOthers
Description

European pre-wholesale pharmaceutical distribution network operating as a sister company within PHOENIX group. Adjacent rather than direct: comparable pharmaceutical distribution capabilities within the same parent group infrastructure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Specific Pharma

Pharmaceutical Distribution & Clinical Trial Supply Servicesspecificpharma.com

Specific Pharma A/S is a Copenhagen-based pharmaceutical services company and subsidiary of PHOENIX group that supplies unlicensed medicines and provides Clinical Trial Supply Management to patients, healthcare professionals, and pharmaceutical companies across Europe.

What Specific Pharma does

Specific Pharma A/S is a Copenhagen-headquartered pharmaceutical services company, founded in 2010 as a spin-off from Danish wholesaler Nomeco to serve unmet demand for unlicensed medicines not marketed in Denmark. The company has since become the largest provider of unlicensed medicines and clinical trial supply in the Nordic countries and operates as a wholly-owned subsidiary of PHOENIX group, the European pharmaceutical wholesaler spanning 26 countries. Its service portfolio combines two interrelated lines: (1) sourcing and distribution of unlicensed and named-patient medicines to patients, healthcare professionals, pharmacies, and hospitals, and (2) Clinical Trial Supply Management (CTSM), which integrates study planning, GMP-compliant packaging and labelling (including Just-In-Time and double-blinded setups), global IMP distribution with temperature-controlled logistics, IMP expiry extension, clinical pass-through, and returns handling. The company also offers MA-Holder services covering post-trial access, shortage mitigation, staggered launches, and discontinuation management, alongside multi-temperature warehousing and distribution across facilities in Denmark, Sweden, and the Netherlands.

The underlying operating backbone is a regulatory-grade pharmaceutical logistics platform with GDP- and GMP-compliant infrastructure, a Quality Management System, and a full set of Danish-issued authorisations (GDP human and veterinary, GMP IMP/human/veterinary, MIA, WDA, EUF for controlled substances). Proprietary operational capabilities include CTSM as a specialised sub-brand, documented IMP expiry extension, and pharmacist-led sourcing across a network of 75 suppliers worldwide. The technology layer is process- and compliance-driven rather than software-driven; no APIs, SDKs, or AI/ML components are disclosed, and the platform is differentiated by regulatory licensing, physical infrastructure, and domain expertise rather than algorithmic tooling.

Specific Pharma monetises through a mix of transaction-fee-based unlicensed medicine distribution, professional services for CTSM engagements, managed services for warehousing and distribution, and fee-based MA-Holder services. The go-to-market is sales-led, executed by territory-specific Business Development Managers and Key Account Managers covering Denmark, Sweden, Holland/Norway, and the Baltics/Iceland/export markets, with direct engagement supported by a LinkedIn presence and a self-service client web portal. Pricing is not publicly disclosed and is contracted per engagement. Roughly half of revenue is generated outside Denmark via export, and the company reports support for 100+ clinical studies across 20+ countries.

Specific Pharma firmographics

Firmographics
Name
Specific Pharma
Legal name
Specific Pharma A/S
Website
https://specificpharma.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
11–50 employees
Short description
Specific Pharma A/S is a Copenhagen-based pharmaceutical services company and subsidiary of PHOENIX group that supplies unlicensed medicines and provides Clinical Trial Supply Management to patients, healthcare professionals, and pharmaceutical companies across Europe.
Ownership category
akta.pro rank

Specific Pharma industry classification

Industry
Product category
Pharmaceutical Distribution & Clinical Trial Supply Services
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences

Keywords

  • Clinical trial supply
  • Unlicensed medicines
  • Pharmaceutical distribution
  • Investigational medicinal products
  • Pharmaceutical logistics services

Where Specific Pharma is headquartered

Location

Headquarters

HQ city
Copenhagen
HQ country
Denmark
HQ region
Europe

Offices4 records

Markets served

Specific Pharma business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Unlicensed Medicines Distribution: Sourcing and distributing unlicensed medicines to patients with unmet medical needs, healthcare professionals, and pharmacies. Services provided on named patient basis, compassionate use permit, or special permit basis.
  2. Clinical Trial Supply Management (CTSM): Comprehensive services for clinical trial supply including product forecasting, study planning, IMP packaging and labeling, global distribution, and returns handling. Supports both global pharmaceutical companies and investigator-initiated trials.
  3. MA-Holder Services: Assisting pharmaceutical companies in making products available across European countries prior to and after marketing authorisation. Includes post-trial access, temporary supply during drug shortages, staggered global launches, and discontinuation management.
  4. Warehousing and Distribution: Storage and distribution services for pharmaceutical companies in Denmark, Sweden, and the Netherlands. Covers ambient, cold chain, frozen temperatures, controlled drugs, and cytostatic agents. GDP-compliant facilities.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels3 records

Specific Pharma product offering

Product offering

Core offering

Specific Pharma sources, warehouses, and distributes unlicensed medicines for patients with unmet medical needs and provides Clinical Trial Supply Management (CTSM) for global clinical trials, including study planning, GMP packaging and labelling, IMP distribution, returns, and IMP expiry extension. Operations are run from GDP- and GMP-compliant facilities in Denmark, Sweden, and the Netherlands, serving pharmaceutical companies, healthcare professionals, and patients in Europe and internationally.

Product overview

Specific Pharma operates as a unified pharmaceutical services platform offering two core service areas: unlicensed medicines provision (including named patient basis, compassionate use, and special permits) and Clinical Trial Supply Management (CTSM). The CTSM department integrates multiple service modules including Study Planning, Packaging and Labeling, Distribution and Returns, and Warehousing across facilities in Denmark, Sweden, and the Netherlands. The MA-Holder Services module extends support throughout the pharmaceutical product lifecycle. Together, these services provide end-to-end pharmaceutical logistics and access solutions for patients, healthcare professionals, and pharmaceutical companies across Europe and globally.

Differentiator

Problem solved

Functional benefit

Brands

  • CTSM (Clinical Trial Supply Management): A highly specialised department providing solutions within clinical trial supply, offering warehousing, distribution, packaging, forecasting, and more for clinical trials.

Products and services

  • Unlicensed Medicines Core offering: sourcing and distributing medicines not marketed in the customer's country on named patient basis, compassionate use permit, or special permit. Served to patients with unmet medical needs, healthcare professionals, and pharmacies in the Nordics and beyond.
  • Clinical Trial Supply Management (CTSM) Comprehensive clinical trial supply service covering warehousing, distribution, packaging, forecasting, and return handling. Supports global pharmaceutical companies and investigator-initiated trials across more than 20 countries.
  • MA-Holder Services Support for pharmaceutical companies throughout the product lifecycle: post-trial patient access, temporary supply during drug shortages, staggered global launches, and discontinuation management across European countries before and after marketing authorisation.
  • Warehousing and Distribution GDP-compliant storage and global distribution of pharmaceutical products, covering ambient, cold chain, frozen temperatures, controlled drugs, and cytostatic agents from facilities in Denmark, Sweden, and the Netherlands.
  • Study Planning Clinical trial supply expertise including product forecast, shipment setup design, ongoing site resupply, packaging design, and comparator sourcing for global studies.
  • Packaging and Labeling GMP repackaging and labelling services for marketed and IMP products, including customised clinical trial packaging, Just-in-Time labelling, double-blinded setup, and secondary packaging to support protocol changes.
  • Distribution and Returns Global IMP distribution with full traceability, IMP expiry extension, Clinical Pass-Through import control with direct delivery to site personnel in Denmark, import/export of controlled substances with annual reporting, and documented return and destruction handling.

Quantifiable outcome

  • Over 1,000 products available quickly
  • +2 more outcomes

Companies that use Specific Pharma

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Specific Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Specific Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • PHOENIX groupcoreOthersSpecific Pharma is a subsidiary of PHOENIX group, Europe's leading pharmaceutical wholesaler operating across 26 European countries. PHOENIX group provides corporate governance, data protection policies, compliance frameworks, and reporting systems. The relationship is parent-subsidiary rather than a traditional partnership.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Specific Pharma competitors and assessment

Company assessment

Broad incumbents

  • Catalent: Large, US-listed pharma services platform covering clinical supply services, softgel and biologics manufacturing, and drug development. Overlaps with Specific Pharma on CTSM within a much broader service portfolio.
  • IQVIA: Largest global CRO and life sciences services firm with integrated clinical trial supplies capabilities. Competes for enterprise CTSM contracts that Specific Pharma also targets, though as part of a far broader clinical research stack.

Direct peers

  • Marken: UPS Healthcare-owned global clinical trial supply chain and logistics provider offering IMP distribution, cold chain, and returns management. Closely mirrors Specific Pharma's CTSM distribution and returns service.
  • Clinigen Group: UK-headquartered specialty pharma company focused on the supply of unlicensed, compassionate-use, and expanded-access medicines plus clinical trial supply services. Directly comparable to Specific Pharma in named-patient distribution and CTSM offerings.
  • Almac Group: Northern Ireland-headquartered pharma services firm providing clinical trial packaging, labeling, distribution, and returns services. Direct overlap with Specific Pharma's Packaging & Labeling and CTSM modules.
  • Fisher Clinical Services (Thermo Fisher Scientific / PPD): Integrated within Thermo Fisher's PPD clinical research services, providing global clinical trial supply, packaging, and distribution. Competes for the same multinational pharma CTSM accounts as Specific Pharma.
  • Durbin (CLH Group): UK-based specialist pharmaceutical wholesaler distributing unlicensed medicines, clinical trial supplies, and named-patient products globally. Directly comparable niche peer for unlicensed medicines and CTSM distribution.

Others

  • Alloga: European pre-wholesale pharmaceutical distribution network operating as a sister company within PHOENIX group. Adjacent rather than direct: comparable pharmaceutical distribution capabilities within the same parent group infrastructure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Specific Pharma social profiles

Digital presence

Specific Pharma compliance and trust

Trust signal

Compliance10 records

Specific Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Specific Pharma leadership team

Management profile

Number of profiles

Profiles10 records

Specific Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Specific Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Specific Pharma

What does Specific Pharma do?

Specific Pharma sources, warehouses, and distributes unlicensed medicines for patients with unmet medical needs and provides Clinical Trial Supply Management (CTSM) for global clinical trials, including study planning, GMP packaging and labelling, IMP distribution, returns, and IMP expiry extension. Operations are run from GDP- and GMP-compliant facilities in Denmark, Sweden, and the Netherlands, serving pharmaceutical companies, healthcare professionals, and patients in Europe and internationally.

When was Specific Pharma founded?

Specific Pharma was founded in 2010. It employs 11 to 50 people.

Where is Specific Pharma based?

Specific Pharma is headquartered in Copenhagen, Denmark, in the Europe region.

How does Specific Pharma make money?

Four revenue lines are on record. Unlicensed Medicines Distribution is the primary driver. The others are clinical Trial Supply Management (CTSM), MA-Holder Services and warehousing and Distribution.

Who are Specific Pharma's main competitors?

Broad incumbents on record are Catalent and IQVIA. Direct peers are Marken, Clinigen Group, Almac Group, Fisher Clinical Services (Thermo Fisher Scientific / PPD) and Durbin (CLH Group). Alloga is listed as an others.

Does Specific Pharma have an API?

No public API is recorded for Specific Pharma.

What industry is Specific Pharma in?

Specific Pharma's product category is Pharmaceutical Distribution & Clinical Trial Supply Services. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales